Results 6 to 10 of 11

In Helsinn Healthcare, the Federal Circuit Offers Guidance on the On-Sale Bar under the AIA

USA - May 4 2017 The sale of a product prior to filing a patent application, or “on-sale bar,” has long been a potential barrier to obtaining a patent in the United…

Eric Furman, Ph.D.

Preparing Biotech Patent Applications - Ten Strategies for Success

USA - March 3 2017 Obtaining issued patents in the biotechnology space can be a challenge. Here is a list of ten patent strategies we recommend for biotechnology…

Michael Fuller

Not Just a Formality? USPTO Sequence Rules May Impact Existing Biotech Portfolios

USA - December 21 2016 Patent applications containing nucleic acid or protein sequences are required to include an electronic sequence listing using a required format and…

Agnes Juang, Ph.D

Getting the Most from Biotech Patents in Europe Without Breaking the Bank: Selecting the Right Countries for Validation

European Union, United Kingdom - October 27 2016 Once a European patent application has been granted, all patentees must then choose to validate the granted application in one or more European…

Agnes Juang, Ph.D

Continental patents a la carte or prix fixe? Biotechnology considerations for the unitary patent in Europe

European Union - September 2 2016 The European unitary patent and Unitary Patent Court (UPC) are slated to go into effect in early 2017. These monumental changes will have a…

Eric Furman, Ph.D.